We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current GPCR market cap is 1.26B. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -26.15M | -30.99M | -32.02M | -33.32M | -45.84M |
| Net Income | -23.86M | -24.5M | -26.04M | -26.03M | -33.98M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -15.91M | -37.7M | -52.56M | -102.78M |
| Net Income | -15.88M | -43.77M | -52.84M | -89.62M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 216.37M | 482.02M | 457.23M | 947.03M | 933.22M |
| Total Liabilities | 23.41M | 29.05M | 27.41M | 26M | 36.42M |
| Total Equity | 192.96M | 452.97M | 429.82M | 921.03M | 896.8M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 38.7M | 111.16M | 97.85M | 482.02M |
| Total Liabilities | 3.17M | 8.93M | 13.01M | 29.05M |
| Total Equity | -22.47M | -64.74M | -115.14M | 452.97M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -57.76M | -79.49M | -34.08M | -60.47M | -80.17M |
| Investing | -87.6M | -268.34M | 1.42M | -203.1M | -392.14M |
| Financing | 169.9M | 451.53M | 702k | 515.41M | 514.65M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.28M | -32.16M | -46.12M | -79.49M |
| Investing | -21.15M | 17.86M | -62.11M | -268.34M |
| Financing | 25.84M | 103.25M | 29.01M | 451.53M |
| Market Cap | 1.26B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 57.26M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 2.99 (11.96%) |
| Company Name | Structure Therapeutics Inc |
| Address |
po box 472, 2nd floor grand cayman KY1-1106 |
| Website | https://www.structuretx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
